Why is the Spire Healthcare share price up 25% today?

The Spire Healthcare share is a big gainer in today’s trading, but the question is whether it’s a good investment to make?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK-based hospital group Spire Healthcare (LSE: SPI) is one of the biggest FTSE gainers today. As I write, its share price is up 25% from yesterday’s close, the highest levels seen since August 2018.

Why has the share price risen?

The sharp upturn follows the proposed acquisition of the company by Australia’s Ramsay Health Care at an offer of 240p per share. To give some perspective, yesterday’s closing price was 193p. In today’s trading, the company’s share price has quickly risen beyond this offer price to 244p. 

If I were looking at these numbers today, it would make sense to buy the share at levels lower than the offer price, which could earn some assured returns in the foreseeable future.

What happens now 

However, that is only if the deal does go through. It may not. There are already reports that institutional shareholders are disappointed with the offer price. According to a Sky News report, they want to push the price up to 400p

If the two groups are in negotiations, then it is possible that the Spire Healthcare share price will rise even higher. But that is all just speculation. And at the Motley Fool, we believe in long-term investing. 

So, the company is of interest to me only if the deal does not go through and there is no more likelihood of a sell-out. To assess if it is indeed a stock I’d like to buy (or not), I looked at the financials first. 

Financials affected, but good outlook

The full-year 2020 was pretty bad for it as elective surgeries were suspended and its contracts with the NHS meant that all its capacity was made available to the service. As a result, its revenues declined by 6.2% from the year before and it ran up an operating loss of £146m. 

This is in sharp contrast to its growing revenue in 2019 and an operating profit of £94m. This, however, gives me hope that it can bounce back as the pandemic recedes. This hope is also bolstered by its performance in the second half of 2020, which showed a revenue increase of 5.9% from the year before.

Also, there are signs of healthy demand in 2021. For instance, its private enquiries are higher than in last year and there is a waiting list for private surgeries, among others.  

Reduced debt

Notably, Spire Healthcare’s net bank debt actually reduced during the year because of advance payments received on its NHS contracts, measured capital spending, and suspension of its final dividend. This is a particular positive in my view, at a time when companies have actually racked up debt

My takeaway

All of this matters, however, only if the company’s acquisition does not go through. For now, I think it is a good idea for me to wait and watch how things progress. If it does not, the Spire Healthcare share does merit consideration.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »